BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22158876)

  • 1. Foot-and-mouth disease virus epitope dominance in the antibody response of vaccinated animals.
    Mahapatra M; Hamblin P; Paton DJ
    J Gen Virol; 2012 Mar; 93(Pt 3):488-493. PubMed ID: 22158876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
    Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
    Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species.
    Aggarwal N; Barnett PV
    J Gen Virol; 2002 Apr; 83(Pt 4):775-782. PubMed ID: 11907326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.
    Cao Y; Li K; Wang S; Fu Y; Sun P; Li P; Bai X; Zhang J; Ma X; Xing X; Zhou S; Bao H; Li D; Chen Y; Li Z; Lu Z; Liu Z
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.
    Opperman PA; Rotherham LS; Esterhuysen J; Charleston B; Juleff N; Capozzo AV; Theron J; Maree FF
    J Virol; 2014 Aug; 88(15):8307-18. PubMed ID: 24829347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.
    Li K; He Y; Wang L; Li P; Wang S; Sun P; Bao H; Cao Y; Liu X; Zhu G; Song Y; Bai X; Ma X; Fu Y; Yuan H; Zhang J; Wang J; Chen Y; Li D; Lou Z; Liu Z; Lu Z
    J Virol; 2021 Oct; 95(21):e0088121. PubMed ID: 34406868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.
    Asfor AS; Upadhyaya S; Knowles NJ; King DP; Paton DJ; Mahapatra M
    J Gen Virol; 2014 May; 95(Pt 5):1104-1116. PubMed ID: 24584474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Foot-and-Mouth Disease Virus-Neutralizing Monoclonal Antibodies Derived From Plasmablasts of Infected Cattle and Their Germline Gene Usage.
    Li K; Wang S; Cao Y; Bao H; Li P; Sun P; Bai X; Fu Y; Ma X; Zhang J; Li D; Chen Y; Liu X; An F; Wu F; Lu Z; Liu Z
    Front Immunol; 2019; 10():2870. PubMed ID: 31867017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
    Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
    Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
    Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
    Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.
    Yang M; Xu W; Goolia M; Zhang Z
    Virol J; 2014 Aug; 11():136. PubMed ID: 25085313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing monoclonal antibodies against porcinophilic foot-and-mouth disease virus mapped to antigenic site 2 by utilizing novel mutagenic virus-like particles to detect the antigenic change.
    Lee HW; Deng MC; Pan CH; Chang HW; Cheng IC
    Vet Microbiol; 2018 Aug; 222():124-131. PubMed ID: 30080667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
    Cubillos C; de la Torre BG; Bárcena J; Andreu D; Sobrino F; Blanco E
    Virol J; 2012 Mar; 9():66. PubMed ID: 22416886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.